Focused Wealth Management’s Bio-Techne TECH Stock Holding History

Focused Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-320	Closed	-$12K	–	716
2018 Q2	$12K	Buy	+320	New	+$12.2K	﹤0.01%	429

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Focused Wealth Management's TECH Position: Q3 2018 in Review

Focused Wealth Management sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 320 shares — an estimated $12K sold.

Focused Wealth Management first reported a position in TECH in Q2 2018 and held it in 1 quarter. The position peaked at $12K in Q2 2018. 344 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

Focused Wealth Management reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
Focused Wealth Management sold 320 Bio-Techne shares in Q3 2018, an estimated $12K.
Focused Wealth Management first reported a position in Bio-Techne in Q2 2018 and held it in 1 quarter.
Focused Wealth Management's Bio-Techne position peaked at $12K in Q2 2018.
344 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on Focused Wealth Management's 13F filing for Q3 2018, filed 13 Nov 2018.